Clinical significance of multi-drug resistance associated protein and P- glycoprotein in patients with bladder cancer

Journal of Urology

Volumn 157, Issue 4, 1997, Pages 1260-1265

  Nakagawa, Masayuki ^a   Emoto, Akio ^b   Nasu, Nobuyoshi ^b   Hanada, Toshikatsu ^b   Kuwano, Michihiko ^b   Cole, Susan P C ^b   Nomura, Yoshio ^b  

^a OITA UNIVERSITY   (Japan)

^b NONE

Author keywords

bladder neoplasms; glycoproteins; proteins

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CISPLATIN; DOXORUBICIN; GLYCOPROTEIN P;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 0030979119     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64944-9     Document Type: Article

References (31)

1. Chen, C., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M. and Roninson, I. B.: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell, 47: 381, 1986.
2. Gros, P., Ben Neriah, Y. B., Croop, J. M. and Housman, D. E.: Isolation and expression of a complementary DNA that confers multidrug resistance. Nature, 323: 728, 1986.
3. Endicott, J. A. and Ling, V.: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annual Rev. Biochem., 58: 137, 1989.
4. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Machie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. and Deeley, R. G.: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258: 1650, 1992.
5. Higgins, C. F.: ABC transporters: from microorganisms to man. Ann. Rev. Cell. Biol., 8: 67, 1992.
6. Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P. and Deeley, R. G.: Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54: 357, 1994.
7. Schneider, E., Horton, J. K., Yang, C.-H., Nakagawa, M. and Cowan, K. H.: Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res., 54: 152, 1994.
8. Nakagawa, M., Schneider, E., Dixon, K. H., Horton, J., Kelley, K., Morrow, C. and Cowan, K. H.: Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdrl) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells. Cancer Res., 52: 6175, 1992.
9. Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L. and Haber, M.: Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. New Engl. J. Med., 334: 231, 1996.
10. Herr, H. W., Laudone, P. and Whitmore, W. F., Jr.: An overview of intravesical therapy for superficial bladder tumors. J. Urol., 138: 1363, 1987.
11. Sternberg, C. N., Yagoda, A., Scher, H. I., Watson, R. C., Herr, H. W., Morse, M. J., Sogani, P. C., Vaughan, E. D., Jr., Bander, N. and Weiselberg, L. R.: M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J. Urol., 139: 461, 1988.
12. Naito, S., Sakamoto, N., Kotoh, S., Goto, K., Matsumoto, T. and Kumazawa, J.: Correlation between the expression of P-glycoprotein and multidrug-resistant phenotype in transitional cell carcinoma of the urinary tract. Eur. Urol., 22: 158, 1992.
13. Shinohara, N., Liebert, M., Wedemeyer, G., Chang, J. H. C. and Grossman, H. B.: Evaluation of multiple drug resistance in human bladder cancer cell lines. J. Urol., 150: 505, 1993.
14. Hasegawa, S., Abe, T., Naito, S., Kotoh, S., Kumazawa, J., Hipfner, D. R., Deeley, R. G., Cole, S. P. and Kuwano, M.: Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Brit. J. Cancer, 71: 907, 1995.
15. Tasaki, Y., Nakagawa, M., Ogata, J., Kiue, A., Tanimura, H., Kuwano, M. and Nomura, Y.: Reversal by a dihydropyridine derivative of non-P-glycoprotein-mediated multidrug resistance in etoposide-resistant human prostatic cancer cell line. J. Urol., 154: 1210, 1995.
16. Park, J., Shinohara, N., Liebert, M., Noto, L., Flint, A. and Grossman, H. B.: P-glycoprotein expression in bladder cancer. J. Urol., 151: 43, 1994.
17. Nooter K., Westerman, A. M., Flens, M. J., Zaman, G. J. R., Scheper, R. J., van Wingerden, K. E., Burger, H., Oostrum, R., Boersman, T., Sonneveld, P., Gratama, J. W., Kok, T., Eggermont, A. M. M., Bosman, F. T. and Stoter, G.: Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin. Cane. Res., 1: 1301, 1995.
18. Brock, I., Hipfner, D. R., Nielsen, B. S., Jensen, P. B., Deeley, R. G., Cole, S. P. and Sehested, M.: Sequential coexpression of the multidrug resistance genes MRP and mdrl and their products in VP-16(etoposide)-selected H69 small cell lung cancer cells. Cancer Res., 55: 459, 1995.
19. Jaffrezou, J. P., Chen, G., Durán, G. E., Kuhl, J.-S. and Sikic, B. I.: Mutation rates and mechanisms of resistance to etoposide determined from fluctuation analysis. J. Natl. Cancer Inst., 86: 1152, 1994.
20. Chin, K. V., Tanaka, S., Darlington, G., Pastan, I. and Gottesman, M. M.: Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem., 265: 221, 1990.
21. Marino, P. A., Gottesman, M. M. and Pastan, L: Regulation of the multidrug resistance gene in regenerating rat liver. Cell Growth Differ., 1: 57, 1990.
22. Kohno, K., Sato, S., Takano, H., Matsuo, K. and Kuwano, M.: The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem. Biophys. Res. Comm., 165: 1415, 1989.
23. Uchiumi, T., Kohno, K., Tanimura, H., Matsuo, K., Sato, S., Uchida, U. and Kuwano, M.: Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differ., 4: 147, 1993.
24. Petrylak, D. P., Scher, H. I., Reuter, V., O'Brian, J. P. and Cordon-Cardo, C.: P-glycoprotein expression in primary and metastatic transitional cell carcinoma of the bladder. Ann. Oncol., 5: 835, 1994.
25. Bahnson, R. R., Becich, M., Ernstoff, M. S., Sandlow, J., Cohen, M. B. and Williams, R. D.: Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy. J. Urol., 152: 2272, 1994.
26. Sandlow, J., Cohen, M. B., Robinson, R. A., Dreicer, R. and Williams, R. D.: DNA ploidy and P-glycoprotein expression as predictive factors of response to neoadjuvant chemotherapy for invasive bladder cancer. Urology, 43: 787, 1994.
27. Pu, Y.-S., Tsai, T.-C., Cheng, A.-L., Tsai, C.-Y., Tseng, N.-F., Su, I.-J., Hsieh, C.-Y. and Lai, M.-K.: Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response. J. Urol., 156: 271, 1996.
28. Clifford, S. C., Thomas, D. J., Neal, D. E. and Lunec, J.: Increased mdrl gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay. Brit. J. Cancer, 69: 680, 1994.
29. Clifford, S. C., Neal, D. E. and Lunec, J.: Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder. Brit. J. Cancer, 73: 659, 1996.
30. Abe, T., Mori, T., Wakabayashi, Y., Nakagawa, M., Akiyama, S., Deeley, R. G., Cole, S. P. C., Koike, K., Kohno, K., Kuwano, M. and Hori, S.: Unpublished data.
31. Beck, W. T., Grogan, T. M., Willman, C. L., Cordon-Cardo, C., Parham, D. M., Kuttesch, J. F., Andreeff, M., Bates, S. E., Berard, C. W., Boyett, J. M., Brophy, N. A., Broxterman, H. J., Chan, H. S., Dalton, W. S., Dietel, M., Fojo, A. T., Gascoyne, R. D., Head, D., Houghton, P. J., Srivastava, D. K., Lehnert, M., Leith, C. P., Paietta, E., Pavelic, Z. P. and Weinstein, R.: Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res., 56: 3010, 1996.